Palvella Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases. Palvella Therapeutics Inc., formerly known as Pieris Pharmaceuticals Inc., is based in WAYNE, Pa.
Info & Links
CEO
Stephen S. Yoder
Headquarters
225 Franklin Street, 26th Floor Boston, MA 02110, UNITED STATES
Palvella Therapeutics, Inc. Common Stock Statistics
Valuation Measures
Market Capitalization2
220.72M
Enterprise Value
201.36M
Enterprise Value/EBITDA(ttm)
-11.61
Price to Earnings Ratio(ttm)
--
Price to Sales(ttm)
5.21
Price to Book(mrq)
1.54
Price to Cash(ytd)
--
Profitability
Gross Margin(ttm)
50.00%
Operating Margin(ttm)
--
Profit Margin(ttm)
-2395.77%
Return on Equity(ttm)
-80.93%
Return on Invested Capital(ttm)
-76.34%
Return on Assets(ttm)
-59.55%
Income Statement
Revenue(ttm)
1.35M
Revenue Per Share(ttm)
1.02
Gross Profit(ttm)
1.35M
EBITDA(ttm)3
-17.34M
Net Income Available to Common(ttm)
-15.95M
Diluted EPS(ttm)
-12.10
Share Statistics
Beta (5Y Monthly)
0.68
52-Week Change
--
S&P 500 52-Week Change
14.01%
S&P 500 Member
Yes
Stock Optionable
Yes
Total Shares Outstanding1
1.32M
Dividend Yield
0.00%
Float4
10.50M
% Held by Insiders
6.39%
% Held by Institutions
40.11%
Balance Sheet
Total Cash(mrq)
19.36M
Total Cash Per Share(mrq)
14.67
Total Debt(mrq)
0.00
Total Debt/Equity(mrq)
0.00%
Current Ratio(mrq)
4.82%
Quick Ratio(mrq)
4.82%
Book Value Per Share(mrq)
12.32
Cash Flow
Operating Cash Flow Per Share(ytd)
-6.31
Free Cash Flow(ytd)
-6.01M
Table Key
mrq = Most Recent Quarter
ttm = Trailing Twelve Months
ytd = Year To Date
Footnotes
Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.
1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.